Axim Biotechnologies Capital Expenditures (CapEx) Growth & History (AXIM)
Axim Biotechnologies's capital expenditures (capex) was $2,839 for fiscal 2024.
View full Axim Biotechnologies company overviewAxim Biotechnologies annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $2,839 | $2,839 | — |
| 2023 | 2023-12-31 | $0 | −$8,710 | — |
| 2022 | 2022-12-31 | $8,710 | −$31,785 | −78.49% |
| 2021 | 2021-12-31 | $40,495 | −$56,829 | −58.39% |
| 2020 | 2020-12-31 | $97,324 | — | — |
| 2016 | 2016-12-31 | $0 | −$16,780 | — |
| 2015 | 2015-12-31 | $16,780 | $16,780 | — |
| 2014 | 2014-12-31 | $0 | — | — |
| 2012 | 2012-12-31 | $100,000 | — | — |
Axim Biotechnologies quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | $2,839 | — | — |
| Q3 2022 | 2022-09-30 | $2,710 | — | — |
| Q3 2012 | 2012-09-30 | $0 | — | — |
Axim Biotechnologies capital expenditures (capex) trends
Between the periods ended 2012-12-31 and 2024-12-31, Axim Biotechnologies's capital expenditures (capex) decreased from $100,000 to $2,839, a change of −$97,161. The latest reported quarter, Q1 2024, shows $2,839.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Axim Biotechnologies source filings ↗